| Business Summary | | Cryo-Cell
International,
Inc.
is
engaged
in
cryogenic
cellular
storage
and
the
design
and
development
of
cellular
storage
devices.
The
Company's
current
focus
is
on
the
processing
and
preservation
of
umbilical
cord
(U-Cord)
blood
stem
cells
for
autologous/sibling
use.
Cryo-Cell
has
pioneered
several
technologies
that
allow
for
the
processing
and
storage
of
specimens
in
a
cryogenic
environment.
These
technologies
include
a
process
for
the
storage
of
fractionated
(separated)
U-Cord
stem
cells
and
the
development
and
patenting
of
a
computer
controlled,
robotically
operated
cryogenic
storage
system. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CCEL
is
engaged
in
cryogenic
storage
and
design
and
development
of
cryogenic
storage
devices
used
in
its
storage
programs.
For
the
six
months
ended
5/31/01,
revenues
totaled
$2.6
million,
up
from
$946
thousand.
Net
income
totaled
$354
thousand
vs.
a
loss
of
$678
thousand.
Revenues
reflect
significant
growth
in
the
processing
and
storage
revenues
from
the
U-Cord(TM)
stem
cell
program.
Net
income
also
reflects
higher
gross
margins
and
higher
other
income. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Daniel Richard, 70 Chairman,
CEO | $189K | Wanda Dearth, 48 Pres,
COO, Director | 83K | Jill Taymans CFO | -- | Gerald Maass, 47 Exec.
VP, Gen. Mang. | 116K | Junior Winokur, 50 Sr.
VP, Corp. Devel., Lamaze Publishing Company; Director | -- | Dollar
amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|